Researchers ID compound that may slow Parkinson’s progression
WHY IT MATTERS
If CTS2444-32 proves effective in human trials, it could offer Parkinson's patients a new treatment option that targets the disease's underlying cause rather than just managing symptoms.
Scientists at Florida International University found a compound called CTS2444-32 that may help slow Parkinson's disease by improving how mitochondria (the energy centers of cells) work. The compound works by reducing a protein called DRP1 that controls mitochondrial function, which helps prevent toxic proteins from building up in the brain—a key problem in Parkinson's.
Researchers at Florida International University (FIU) have identified a compound that boosts the function of mitochondria (cells’ powerhouses) and may slow the progression of Parkinson’s disease. The scientists found that by reducing the activity of a protein called dynamin-related protein 1 (DRP1), which regulates mitochondrial function, the compound, CTS2444-32, reduced the buildup of toxic protein […] The post Researchers ID compound that may slow Parkinson’s progression app